Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
about
Pathophysiology and treatment of bacterial meningitisInfected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniaeDaptomycin in experimental murine pneumococcal meningitis.Treatment of bacterial meningitis.Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin.Concentrations of cefpirome in cerebrospinal fluid of children with bacterial meningitis after a single intravenous dose.Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children witDisposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.New species genetic approach to identify strains of mitis group streptococci that are donors of rifampin resistance to Streptococcus pneumoniae.New mutations and horizontal transfer of rpoB among rifampin-resistant Streptococcus pneumoniae from four Spanish hospitalsBacterial meningitis in children.Management of infections due to antibiotic-resistant Streptococcus pneumoniaePharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Killing activities of trovafloxacin alone and in combination with beta-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically acBacterial Meningitis: Principles and Practical Aspects of Therapy.Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections.The antibiotic and anti-inflammatory treatment of bacterial meningitis in adults: do we have to change our strategies in an era of increasing antibiotic resistance?Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.Evaluation of CP-99,219, a new fluoroquinolone, for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis.Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis.Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae.In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporinsNoncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.Rifampin use in acute community-acquired meningitis in intensive care units: the French retrospective cohort ACAM-ICU study.Levofloxacin disposition in cerebrospinal fluid in patients with external ventriculostomyAdjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.Acute bacterial meningitis in infants and children: epidemiology and management.Bacterial meningitis: new therapeutic approaches.Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone?Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies.Bacterial meningitis: an update of new treatment options.Gemifloxacin is effective in experimental pneumococcal meningitisMoxifloxacin in the therapy of experimental pneumococcal meningitis.Clindamycin therapy of experimental meningitis caused by penicillin- and cephalosporin-resistant Streptococcus pneumoniae.Overton's rule helps to estimate the penetration of anti-infectives into patients' cerebrospinal fluid[Acute care of patients with bacterial meningitis].Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
P2860
Q24628983-79844F53-0CCD-4D53-9C1D-3CA5E505E7FBQ28378935-D80A5D79-D6D7-4FEA-91B9-BE9309B5BD83Q33437256-D80B6AC2-E339-44D9-A5BC-CF782AA2752DQ33544695-1BDF1FF6-C81E-43CD-BD25-3843B8A5EA38Q33689547-37C97B1F-B3C7-4A32-9615-9C6BFC6F4F2DQ33690784-6BFD2EA9-F0C6-42FF-9B90-F1FFA30CB115Q33692927-8DF7355C-A6A6-469C-80FE-B5D2B629105FQ33694884-CFB3E4AC-53E8-46A2-8CFA-AD939C5E5F05Q33735606-98EB71BF-57C0-4191-831F-432F2393F08AQ33836747-E8717B18-7910-4129-9BE3-0EEC5DF05CE5Q33929062-0E66D6DE-6182-4EFE-B57D-C8753886FD32Q33975374-5A3786B1-ECB7-4A8B-80F9-D1E9AE30005EQ33976683-9AAAADCC-0994-448C-A1E7-03767D7A3A21Q33977786-7827C934-14D3-47B7-9B67-03ACA816FE2AQ34092272-623B97ED-D350-460E-B590-14C380B2D300Q34142328-6464CF31-A10C-407B-984B-9D1DACBA05ABQ34402548-4D1CCA98-A832-40EE-A69F-E347B6839E4CQ34487226-7DF3BC3D-3981-4F0D-8CAF-1112EBAA1D7FQ34720054-44EC36D8-0393-4519-927F-80E59EF96A67Q35118221-D00F29DF-17D8-4B59-9CA4-49306C6103F4Q35118924-9EFB6FB2-3DA2-4B75-8C2B-FC91623F9238Q35119049-C4F80DEA-D8A4-4282-A6A4-71F58B1D3207Q35121060-CE44B91C-FF31-4B02-95F4-7528E08B6D28Q35122014-21B78DA4-8D65-4D84-A6C8-F2D06707AB8DQ35125164-51EF1AA1-A991-4A6C-AFD7-29764D517EC4Q35137976-425E914D-5F4C-4361-9AE3-E58BEF16797CQ35755083-167F8B13-DF87-47BB-B8BD-D300661DFF50Q36047066-03E30D6A-B340-4757-887D-A179F5838C35Q36171566-69149EC4-3DFE-49D6-945F-10505A2AA7EAQ37945754-2309F1B2-95B4-4D72-86D3-CEEFDBC9338AQ38145360-28E9FE9A-6A9E-47D3-8366-45246DCCC732Q38466769-236A35EA-75FF-4431-823D-DEF3276A907AQ38539643-F2A5006C-EEF5-4124-9B29-6770CA40195EQ38570487-BE577A18-95D2-48E5-8A46-E13B76ACF1ACQ39473262-E110BE1D-53BF-45DE-B439-562B07899293Q39557705-E9C58516-E4BC-4746-9483-4A70B9F3C9A9Q39781217-3C91F0BE-C852-488C-BB09-A9CEAD66E11BQ40600560-02395931-E814-4C0B-A3F8-2ADEA68C29FFQ41331946-ED291F64-856B-4650-BFC2-86ADE026CF14Q41831644-CB1EC43A-F118-4ECA-A06F-1343F441C7F5
P2860
Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@ast
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@en
type
label
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@ast
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@en
prefLabel
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@ast
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@en
P2093
P2860
P356
P1476
Effect of dexamethasone on the ...... stant pneumococcal meningitis.
@en
P2093
P2860
P304
P356
10.1128/AAC.38.6.1320
P407
P577
1994-06-01T00:00:00Z